Skip to main content

Table 3 Patient reactions to psychiatrist’s offer of long-acting injectable antipsychotic treatment

From: Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia

LAI-naïve patient reactions to

n (%)

Prescribed a LAI, n

LAI offer (n = 19)

 

(% of reaction category)

 Favorable

3 (16)

3 (100)

 Neutral/passive

9 (47)

6 (67)

 Unfavorable/concerned

7 (37)

2 (29)

Verbalized patient reasons for LAI acceptance (favorable) a , n

 Adherence benefits

 

3

 Extended/consistent efficacy

 

1

 Lessen oral pill burden

 

1

Verbalized patient reasons for LAI refusal (unfavorable) b , n

 Fear of needles

 

3

 Dosing logistics/administration

 

2

 Side effect concerns

 

2

 Unclear

 

1

  1. aTwo patients cited 1 other benefit in addition to adherence.
  2. bOne patient cited 2 reasons for refusal of LAI.
  3. LAI, long-acting injectable antipsychotic.